ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in November 2026. Updated November 5.
A roundup of FDA’s actions in November 2026.
FDA Output, November 2026
×
